Related references
Note: Only part of the references are listed.Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)
Pei-Fang Wei
CHINESE MEDICAL JOURNAL (2020)
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Wen Zhang et al.
CLINICAL IMMUNOLOGY (2020)
Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study
Yan Zhang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study
Luyan Chen et al.
JOURNAL OF INFECTION (2020)
Co-infections in people with COVID-19: a systematic review and meta-analysis
Louise Lansbury et al.
JOURNAL OF INFECTION (2020)
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Victor J. Costela-Ruiz et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review
Awadhesh Kumar Singh et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
Mild versus severe COVID-19: Laboratory markers
Thirumalaisamy P. Velavan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
COVID-19 and the liver
Dinesh Jothimani et al.
JOURNAL OF HEPATOLOGY (2020)
Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study
Guyi Wang et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection
Xingzhong Hu et al.
CLINICA CHIMICA ACTA (2020)
COVID-19 and multisystem inflammatory syndrome in children and adolescents
Li Jiang et al.
LANCET INFECTIOUS DISEASES (2020)
High-density lipoproteins during sepsis: from bench to bedside
Sebastien Tanaka et al.
CRITICAL CARE (2020)
Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in Sepsis
Mark Trinder et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Lipid testing in infectious diseases: possible role in diagnosis and prognosis
Sebastian Filippas-Ntekouan et al.
INFECTION (2017)
The Association between Cytomegalovirus Infection, Obesity, and Metabolic Syndrome in US Adult Females
Shannon Fleck-Derderian et al.
OBESITY (2017)
Low HDL levels in sepsis versus trauma patients in intensive care unit
Sebastien Tanaka et al.
ANNALS OF INTENSIVE CARE (2017)
High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
Elizabeth M. Gordon et al.
FRONTIERS IN PHARMACOLOGY (2016)
Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission
Yu-Fen Chien et al.
JOURNAL OF CRITICAL CARE (2015)
Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue Outcome
Hope H. Biswas et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
HDL in sepsis - risk factor and therapeutic approach
Emily E. Morin et al.
FRONTIERS IN PHARMACOLOGY (2015)
Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes
F. Apostolou et al.
ATHEROSCLEROSIS (2010)
Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis
Ming-Hung Tsai et al.
JOURNAL OF HEPATOLOGY (2009)
Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase
Jia Wan et al.
PROTEOMICS (2006)
Lipoprotein metabolism in patients with severe sepsis
HJ van Leeuwen et al.
CRITICAL CARE MEDICINE (2003)
Share Paper
